CClinicalTrials.gg
CompletedNCT06241716Updated May 7, 2026

Ultrasound-assisted Versus Real-time Ultrasound-guided Combined Spinal-epidural Anesthesia in Elderly Patients

An interventional study of Ultrasound-assisted localization, US-AS and Real-time ultrasound guidance, US-RTG in Ultrasound Therapy; Complications, sponsored by Tongji Hospital. Completed at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Tongji Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This prospective randomized controlled trial aims to compare the clinical efficacy and safety of real-time ultrasound guidance (US-RTG) versus static ultrasound-assisted mapping (US-AS) for combined spinal-epidural anesthesia (CSEA) via the paramedian approach in elderly patients aged 60 years and older undergoing orthopedic surgery.

Read the detailed description

Elderly patients frequently present with age-related spinal degeneration, which significantly increases the technical difficulty of combined spinal-epidural anesthesia (CSEA) and elevates the risk of puncture-related complications. Ultrasound guidance has emerged as a valuable tool to improve neuraxial anesthesia outcomes, but the optimal ultrasound technique for CSEA in this vulnerable population remains unclear.

Two predominant ultrasound approaches are currently utilized in clinical practice: static ultrasound-assisted mapping (US-AS), which involves pre-procedural identification of spinal landmarks, and real-time ultrasound guidance (US-RTG), which provides continuous visualization of needle advancement during the procedure. However, there is limited high-quality evidence directly comparing these two techniques specifically for CSEA in elderly patients undergoing orthopedic surgery.

This prospective randomized controlled trial will enroll 96 eligible patients aged 60 years and older scheduled for elective orthopedic surgery under CSEA. Eligible patients will be randomly assigned in a 1:1 ratio to receive either US-RTG or US-AS for CSEA placement via the paramedian approach.

The primary outcome measure is the first-attempt success rate, defined as successful dural puncture achieved with a single skin puncture and no needle redirections. Secondary outcome measures include the number of subarachnoid (SA) needle insertion attempts, number of skin punctures, overall incidence of adverse events (AEs), and patient satisfaction scores. Subgroup analyses will be performed to evaluate the efficacy of the two techniques across varying epidural dimensions, and a learning curve analysis will be conducted to assess the procedural proficiency plateau for US-RTG.

The results of this study will provide evidence-based guidance for the selection of optimal ultrasound techniques for CSEA in elderly patients, with the potential to reduce procedural tissue trauma, minimize puncture-related complications, and improve patient safety and satisfaction.

02

Conditions studied

  • Ultrasound Therapy; Complications
03

In context

Lead sponsor

Tongji Hospital is the lead sponsor of 373 studies on the registry; 204 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Elderly patients (≥ 60 years old);
  • ASA Grade I to IV.

Exclusion criteria

Exclusion Criteria:

  • Severe obesity (BMI>35kg/m2);
  • Spinal deformity or surgical history;
  • Allergic to local anesthetics;
  • There are coagulation disorders;
  • Communication barriers
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
96 participants (actual)

Study arms

  • Active comparator
    Ultrasound-assisted localization, US-AS

    Patients in the US-AS group will undergo a pre-procedural ultrasound scan to identify the optimal intervertebral space, measure the depth to the epidural space, and mark the skin entry point and estimated puncture angle. The ultrasound probe will then be removed, and the combined spinal-epidural anesthesia (CSEA) procedure will be performed via the paramedian approach using the pre-marked landmarks.

    Procedure: Ultrasound-assisted localization, US-AS · Procedure: Real-time ultrasound guidance, US-RTG

  • Experimental
    Real-time ultrasound guidance, US-RTG

    Patients in the US-RTG group will undergo CSEA via the paramedian approach under continuous real-time ultrasound visualization. The procedure will be performed using either the in-plane technique in the paracentral transverse plane, allowing direct visualization of needle advancement through the soft tissues and into the epidural and subarachnoid spaces.

    Procedure: Ultrasound-assisted localization, US-AS · Procedure: Real-time ultrasound guidance, US-RTG

Interventions

  • ProcedureUltrasound-assisted localization, US-AS

    In the US-AS group, ultrasonic prescan to determine the best intervertebral space, best puncture Angle and best puncture depth. The optimal puncture section considered by the operator was selected to record the best gap, puncture Angle and depth.

  • ProcedureReal-time ultrasound guidance, US-RTG

    In the US-RTG group, the optimal puncture section considered by the operator was selected and recorded directly in the plane of the paracentral transverse section, out of the plane of the paracentral sagittal section or in the plane of the paracentral sagittal section for real-time ultrasound guided lumbar epidural anesthesia.

06

What researchers measure

Primary outcomes

  1. First-attempt success

    The proportion of the first successful puncture to the total successful puncture

    Time frame: 1 year

Secondary outcomes

  1. Operating time

    The time from the contact of the ultrasonic probe to the end of the operation (In seconds).

    Time frame: 1 year

  2. Location time

    The time required for pre-scanning and positioning (In seconds).

    Time frame: 1 year

  3. Depth and width of posterior dural complex (DPEC, WPEC)

    DPEC = Depth to Posterior Epidural Complex, WPEC = Width of Posterior Epidural Complex

    Time frame: 1 year

  4. Number of skin punctures

    Count the number of skin piercings (In seconds).

    Time frame: 1 year

  5. Number of redirections

    Count the number of needle redirection

    Time frame: 1 year

  6. Patient satisfaction score (How satisfied the patient is with the whole procedure)

    1 is very dissatisfied; 2 is not satisfied; 3 is generally satisfied; 4 are relatively satisfied; A score of 5 is very satisfactory

    Time frame: 1 year

  7. SA needle insertion attempts

    Times of SA needle inserting via the epidural needle

    Time frame: 1 year

  8. Adverse events (AEs)

    Adverse events that occurred during the operation process.

    Time frame: 1 year

  9. Procedural difficulty

    Procedural difficulty of palpating spinous processes was assessed as Grade 1 (palpable), Grade 2 (somewhat palpable), or Grade 3 (impalpable)

    Time frame: 1 year

07

Study locations

1 site
  • Tianzhu Liu
    Wuhan, Hubei 430000, China
08

References and documents

Study documents

  • Study protocol · Feb 1, 2024
  • Statistical analysis plan · Feb 1, 2024
  • Informed consent form · Feb 1, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06241716
Lead sponsor
Tongji Hospital
Responsible party
Tianzhu Liu (Principal Investigator, Tongji Hospital) — Principal investigator
First posted
Feb 5, 2024
Start date
Feb 15, 2024
Primary completion
Oct 20, 2025
Completion
Oct 20, 2025
Last update
May 7, 2026

Study contacts

Wei Mei, Ph.D.
principal investigator · Tongji Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion